Hong Kong equities extended gains into the afternoon session on August 20, with all three major indexes advancing. As of press time, the Hang Seng Index rose 1.22%, or 312.22 points, to 25,807.29; the Hang Seng Tech Index climbed 1.29% to 4,742.55; and the HSCEI added 1.43% to 8,592.33. Innovator drug stocks erupted in a broad-based rally, gold miners advanced in unison, while tech names traded mixed with Kuaishou slumping over 10% post-results.

Innovator Drug Stocks Erupt; Everest Medicines Rockets Nearly 60%

As of press time, Everest Medicines (01952.HK) soared more than 58% to HK$37.72; CSPC Pharmaceutical Group (01177.HK) surged over 13% to HK$5.42; Sino Biopharmaceutical (01093.HK) jumped nearly 10% to HK$9.55; WuXi Biologics (02269.HK) advanced over 4% to HK$50.00; WuXi AppTec (02359.HK) and BeiGene (06160.HK) each gained about 3%, with both notching fresh all-time highs.

On the catalyst front, a breakthrough in Moderna's mRNA vaccine development lifted global innovator drug sentiment. Several pharmaceutical firms delivered robust interim results, with Sino Biopharmaceutical and CSPC Pharma attracting inflows post-earnings. Everest Medicines' pipeline progress has fueled market optimism around its commercialisation prospects.

Tech Names Mixed; Kuaishou Tumbles Over 10% Post-Results

As of press time, Kuaishou-W (01024.HK) slumped over 10% to HK$34.00 on turnover of nearly HK$6.7 billion; Alibaba-W (09988.HK) rose nearly 3% to HK$127.7; Baidu-SW (09888.HK) gained over 3% to HK$93.05; JD.com-SW (09618.HK) added about 3% to HK$116.1; Tencent Holdings (00700.HK) edged up nearly 2% to HK$455.6.

Kuaishou's earlier earnings release missed market expectations, prompting multiple major banks to slash target prices. The stock's short-selling ratio spiked to as high as 30.9% during the half-day session. Zhang Zhiwei of Pinpoint Capital warned that Kuaishou shares may not have found a bottom yet. Meanwhile, all eyes are on Alibaba's upcoming results, seen as a key variable for the market's next move.

Gold Miners Advance as Spot Gold Breaks US$4,500

As of press time, Lingbao Gold (03330.HK) surged nearly 8% to HK$23.76; Zijin Mining Group (02899.HK) jumped over 6% to HK$37.00; Chifeng Gold (06693.HK) gained over 5% to HK$41.32.

The US Treasury's announcement of expanded long-dated bond buybacks drove Treasury yields lower, sending spot gold past US$4,500 to a two-month high. Analysts noted that gold has broken out of its consolidation range, with a target zone of US$4,600–4,800 in sight.

In other movers, Nine Dragons Paper (02689.HK) issued a positive profit alert forecasting up to a doubling of full-year earnings, yet the stock still tumbled over 12% to HK$6.96, extending its losing streak to four sessions. Bank of East Asia (00023.HK) hiked its interim dividend by 18%, sending shares up over 4% to HK$16.98. AAC Technologies (02018.HK) posted a 2.9% rise in half-year profit, but its stock slid over 6% to HK$38.96.